Sugammadex to Facilitate Neurologic Assessment in Severely Brain-Injured Patients: A Retrospective Analysis and Practical Guidance.

Cureus · 2022 · PMC9673186 · PMID 36407180

Europe PMC DOI

hedged sentence

0.0781

closest p · 1.6× alpha

0.0781

boldest claim

The sentences

did not reach statistical significancep=0.0781so close (0.05 < p ≤ 0.1)

88, median change -5.5 [95% CI -23-3], n=4), though the change in median MAP did not reach statistical significance within either subgroup (p=0.0781 and p=0.375, respectively).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.